{
    "clinical_study": {
        "@rank": "48649", 
        "acronym": "THRIVE-III", 
        "arm_group": {
            "arm_group_label": "Study arm", 
            "arm_group_type": "Experimental", 
            "description": "geko neuromuscular electrostimulation"
        }, 
        "brief_summary": {
            "textblock": "The primary objective of this study is to examine the flow characteristics of deep venous\n      flow in the leg veins using Doppler ultrasound imaging and how this flow is modified by the\n      application of a plaster and with a geko\u2122 device in healthy volunteers"
        }, 
        "brief_title": "Geko\u2122 Plaster Cast Study, Deep Vein Thrombosis (DVT) Prophylaxis", 
        "condition": "Deep Vein Thrombosis", 
        "condition_browse": {
            "mesh_term": [
                "Thrombosis", 
                "Venous Thrombosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Be in good general health and fitness.\n\n          2. Aged between 18 and 65 years.\n\n          3. Free of significant abnormal findings as determined by medical history (specifically\n             an absence of DVT or haematological disorders or indications), screening physical\n             examination, vital signs (sitting blood pressure, sitting pulse rate, sitting\n             respiratory rate and body temperature) and duplex ultrasound)\n\n          4. BMI between 18 and 34\n\n          5. No history or signs of drug abuse (including alcohol), licit or illicit.\n\n          6. Has not used any medications (prescribed or over-the-counter including herbal\n             remedies) judged to be significant by the Principal Investigator during the thirty\n             (30) days preceding the study, and agrees not to use any medications during the\n             course of the study without informing the Research Team.\n\n          7. Able to understand the Volunteer Information Sheet and signed the written Informed\n             Consent Forms.\n\n          8. Able and willing to follow the Protocol requirements.\n\n        Exclusion Criteria:\n\n          1. Previous leg fracture. (within the last 12 months)\n\n          2. Any evidence of organ dysfunction, or any clinically significant deviation from\n             normal in the physical determinations.\n\n          3. History or signs of haematological disorders (especially in relation to clotting or\n             coagulation or previous Deep or superficial vein thrombosis/pulmonary embolism) or\n             familiar history of such.\n\n          4. Peripheral arterial disease (ABPI<0.9), clinically significant varicose veins or\n             lower limb ulceration.\n\n          5. Musculoskeletal disorders (such as pain during exercise of lower limb, rheumatoid or\n             osteoarthritis).\n\n          6. Neurological disorders,(such as stroke, multiple sclerosis)\n\n          7. Recent surgery (such as abdominal, gynaecological, hip knee replacement).\n\n          8. Recent trauma to lower limbs.\n\n          9. Chronic Obesity (BMI Index >34).\n\n         10. Pregnancy.\n\n         11. Any Medication judged to be significant by the Principal Investigator.\n\n         12. Tobacco consumption\n\n         13. History of disorders of the gastrointestinal, hepatic, renal, cardiovascular,\n             endocrine, neurological, dermatological, rheumatologic, metabolic (including\n             diabetes), psychiatric, haematological (especially in relation to clotting or\n             coagulation), or systemic disease judged to be significant.\n\n         14. A pulse rate of less than 50 beats/minute, a sitting systolic blood pressure >160 or\n             <80 mmHg and/or a sitting diastolic pressure of >90 or <60 mmHg.\n\n         15. Any significant illness during the four (4) weeks preceding the screening period of\n             the study.\n\n         16. Any contraindication to blood sampling.\n\n         17. Donation of blood during the eight (8) weeks preceding the screening period of the\n             study or during the investigation.\n\n         18. Participation in any clinical study during the 8 weeks preceding the dosing period of\n             the study\n\n         19. Fitted with a pacemaker or defibrillator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01979328", 
            "org_study_id": "THRIVE-III"
        }, 
        "intervention": [
            {
                "arm_group_label": "Study arm", 
                "intervention_name": "geko", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Study arm", 
                "intervention_name": "Plaster cast", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Deep Vein Thrombosis", 
        "lastchanged_date": "November 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Southampton", 
                    "country": "United Kingdom", 
                    "zip": "SO16 6YD"
                }, 
                "name": "Southampton University Hospital"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Efficacy of a Neuromuscular Stimulation Device (Geko\u2122) in Promoting Blood Flow in a Plaster Cast as a Way of Offering Mechanical DVT Prophylaxis", 
        "other_outcome": {
            "description": "None validated questionnaire and a scoring index to assess comfort of the device", 
            "measure": "acceptability and tolerance (composite endpoint)", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Blood flow", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01979328"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "23999610", 
            "citation": "Warwick DJ, Shaikh A, Gadola S, Stokes M, Worsley P, Bain D, Tucker AT, Gadola SD. Neuromuscular electrostimulation viathe common peroneal nerve promotes lower limb blood flow in a below-kneecast: A potential for thromboprophylaxis. Bone Joint Res. 2013 Sep 2;2(9):179-85. doi: 10.1302/2046-3758.29.2000176. Print 2013."
        }, 
        "secondary_outcome": {
            "measure": "microcirculatory blood flow", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "source": "University Hospital Southampton NHS Foundation Trust.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Southampton NHS Foundation Trust.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}